
UK Researchers Restore Sleep in Alzheimer's Mice by Targeting Immune Cells, Not Plaques
University of Kentucky researchers found that removing 87% of brain immune cells in mice with Alzheimer's-like pathology restored over two hours of daily sleep without reducing amyloid plaques. The study identifies microglia-driven inflammation, not plaque accumulation itself, as the primary cause of sleep disruption. This suggests new therapeutic targets for improving sleep and potentially slowing disease progression.













